HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

Benzinga · 03/10 17:07
HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.